Common use of Covenant Defeasance and Waiver Clause in Contracts

Covenant Defeasance and Waiver. Upon the Company’s exercise of the option described in Section 402(3) of the Indenture with respect to the Notes, in addition to the other obligations permitted to be released by Section 402(3), the Company shall be released from its obligations to comply with any term, provision or condition under Sections 3.01, 3.02 and 3.05 of this Ninth Supplemental Indenture with respect to the Notes. The provisions of Sections 3.01, 3.02 and 3.05 of this Ninth Supplemental Indenture may be waived in accordance with Section 1005 of the Indenture.

Covenant Defeasance and Waiver. Upon the Company’s exercise of the option described in Section 402(3) of the Indenture with respect to the Notes, in addition to the other obligations permitted to be released by Section 402(3), the Company shall be released from its obligations to comply with any term, provision or condition under Sections 3.01, 3.02 and 3.05 of this Ninth Tenth Supplemental Indenture with respect to the Notes. The provisions of Sections 3.01, 3.02 and 3.05 of this Ninth Tenth Supplemental Indenture may be waived in accordance with Section 1005 of the Indenture.

Covenant Defeasance and Waiver. Upon the Company’s exercise of the option described in Section 402(3) of the Indenture with respect to the 2017 Notes, in addition to the other obligations permitted to be released by Section 402(3), the Company shall be released from its obligations to comply with any term, provision or condition under Sections 3.01, 3.01 and 3.02 and 3.05 of this Ninth Fourth Supplemental Indenture with respect to the 2017 Notes. The provisions of Sections 3.01, 3.01 and 3.02 and 3.05 of this Ninth Fourth Supplemental Indenture may be waived in accordance with Section 1005 of the Indenture.

Covenant Defeasance and Waiver. Upon the Company’s exercise of the option described in Section 402(3) of the Indenture with respect to the Notes, in addition to the other obligations permitted to be released by Section 402(3), the Company shall be released from its obligations to comply with any term, provision or condition under Sections 3.01, 3.02 and 3.05 of this Ninth Eighth Supplemental Indenture with respect to the Notes. The provisions of Sections 3.01, 3.02 and 3.05 of this Ninth Eighth Supplemental Indenture may be waived in accordance with Section 1005 of the Indenture.

Covenant Defeasance and Waiver. Upon the Company’s exercise of the option described in Section 402(3) of the Indenture with respect to the Notes, in addition to the other obligations permitted to be released by Section 402(3), the Company shall be released from its obligations to comply with any term, provision or condition under Sections 3.01, 3.02 and 3.05 of this Ninth Seventh Supplemental Indenture with respect to the Notes. The provisions of Sections 3.01, 3.02 and 3.05 of this Ninth Seventh Supplemental Indenture may be waived in accordance with Section 1005 of the Indenture.

Covenant Defeasance and Waiver. Upon the Company’s exercise of the option described in Section 402(3) of the Indenture with respect to the 2023 Notes, in addition to the other obligations permitted to be released by Section 402(3), the Company shall be released from its obligations to comply with any term, provision or condition under Sections 3.01, 3.01 and 3.02 and 3.05 of this Ninth Fifth Supplemental Indenture with respect to the 2023 Notes. The provisions of Sections 3.01, 3.01 and 3.02 and 3.05 of this Ninth Fifth Supplemental Indenture may be waived in accordance with Section 1005 of the Indenture.

Covenant Defeasance and Waiver. Upon the Company’s exercise of the option described in Section 402(3) of the Indenture with respect to the 2022 Notes, in addition to the other obligations permitted to be released by Section 402(3), the Company shall be released from its obligations to comply with any term, provision or condition under Sections 3.01, 3.01 and 3.02 and 3.05 of this Ninth Second Supplemental Indenture with respect to the 2022 Notes. The provisions of Sections 3.01, 3.01 and 3.02 and 3.05 of this Ninth Second Supplemental Indenture may be waived in accordance with Section 1005 of the Indenture.

Covenant Defeasance and Waiver. Upon the Company’s exercise of the option described in Section 402(3) of the Indenture with respect to the 2015 Notes, in addition to the other obligations permitted to be released by Section 402(3), the Company shall be released from its obligations to comply with any term, provision or condition under Sections 3.01, 3.01 and 3.02 and 3.05 of this Ninth First Supplemental Indenture with respect to the 2015 Notes. The provisions of Sections 3.01, 3.01 and 3.02 and 3.05 of this Ninth First Supplemental Indenture may be waived in accordance with Section 1005 of the Indenture.